Partnering Overview

Partnering Combinatorial Cell Culture™ with pharmaceutical and biotech companies concerned with the problem of differentiating stem cells is an important aspect of Plasticell’s business model. We actively pursue alliances and we also welcome independent enquiries from leading commercial and academic groups.

Combinatorial Cell Culture™ is the state-of-the-art method for discovering conditions to direct differentiation of stem cells into specific lineages. Unlike commercially available kits and media which are limited to using and producing certain stem cell types, Combinatorial Cell Culture™ is a process that allows researchers to customize protocols and outcomes to their specific needs. In addition, a high throughput approach to stem cell differentiation is a rapid, efficient and cost-effective means for industry partners to perform complex research projects.

As Plasticell’s core focus is in drug discovery, not on the production or use of cell products for research or therapy, we have a very favorable and flexible approach to technology and product licensing.

For  further  information  on  partnering  opportunities  please  contact contact2008@plasticell.co.uk